Phakomatosis pigmentovascularis

Phakomatosis pigmentovascularis (PPV) is a rare congenital disorder characterized by the coexistence of a widespread vascular birthmark (capillary malformation or port-wine stain) and an extensive pigmentary skin lesion, such as dermal melanocytosis (Mongolian spots), nevus spilus, or nevus of Ota. The condition is present at birth and results from a somatic mosaic mutation, most commonly in the GNA11 or GNAQ genes, which regulate cell signaling pathways involved in both melanocyte and vascular development. Several subtypes have been described based on the specific combination of vascular and pigmentary lesions. The skin findings are typically widespread, often involving large areas of the trunk, extremities, and face. Beyond the skin, phakomatosis pigmentovascularis can affect multiple organ systems. Ocular involvement, including melanosis oculi (pigmentation of the sclera and uveal tract) and glaucoma, is relatively common. Some patients develop neurological complications such as seizures or developmental delay, particularly when associated with Sturge-Weber-like leptomeningeal vascular anomalies. Limb asymmetry or overgrowth may also occur in affected individuals, overlapping with features seen in Klippel-Trenaunay syndrome. Systemic complications depend on the extent and location of the vascular and pigmentary lesions. There is no cure for phakomatosis pigmentovascularis, and management is primarily symptomatic and supportive. Pulsed dye laser therapy may be used to treat port-wine stains, while Q-switched laser therapy can address pigmentary lesions. Glaucoma requires ophthalmologic monitoring and treatment. Neurological complications are managed with standard anticonvulsant therapy when needed. Regular multidisciplinary follow-up involving dermatology, ophthalmology, and neurology is recommended to monitor for complications and optimize quality of life.

Common questions about Phakomatosis pigmentovascularis